1	Un	Un		C0205447_1	calificador_1	0-2	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	de	de	SPS00	C0332285	atributo	12-14	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	73	73		-	-	15-17	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	años	año	NCMP000	C0439234	calificador	18-22	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	con	con	SPS00	C0332287	atributo	23-26	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	antecedente	antecedente	NCMS000	C0455686_1	situación_1	27-38	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	de	de	SPS00	C0455686_2	situación_2	39-41	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
9	enfermedad	enfermedad	NCFS000	C0455686_3	situación_3	42-52	749_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
10	renal	renal	AQ0CS0	C0455686_4	situación_4	53-58	749_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-	9	156	LOC
11	crónica	crónico	AQ0FS0	C0205191	calificador	59-66	749_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	9	156	Modif
12	que	que	PR0CN000	-	-	67-70	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	presenta	presentar	VMIP3S0	-	-	71-79	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	un	un		C0205447_1	calificador_1	80-82	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
15	cuadro	cuadro	NCMS000	-	-	83-89	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
16	de	de	SPS00	C0332285	atributo	90-92	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	5	5	Z	-	-	93-94	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	días	d	NCMP000	-	-	95-99	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	de	de	SPS00	C0332285	atributo	100-102	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	fiebre	fiebre	NCFS000	C0015967	hallazgo	103-109	749_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
21	,	,	Fc	-	-	109-110	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
22	cefalea	cefalea	NCFS000	C0018681	hallazgo	111-118	749_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
23	y	y	CC	C1706368	calificador	119-120	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
24	confusión	confusión	NCFS000	C0009090	hallazgo	121-130	749_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
25	,	,	Fc	-	-	130-131	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
26	acompañado	acompañar	VMP00SM	-	-	132-142	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
27	de	de	SPS00	C0332285	atributo	143-145	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
28	una	una		C0205447_1	calificador_1	146-149	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
29	crisis	crisis	NCFN000	C0036572#C0014544_1	hallazgo_1	150-156	749_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
30	epiléptica	epiléptico	NCFS000	C0036572#C0014544_2	hallazgo_2	157-167	749_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-	29	299	MultiE
31	tónico-clónica	tónico-clónica	AQ0FS00	-	-	168-182	749_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	29	156	LOC
32	.	.	Fp	-	-	182-183	749_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	El	el	DA0MS0	-	-	184-186	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	estado	estar	VAP00SM	C0449440_1	atributo_1	187-193	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	clínico	clínico	NCMS000	C0449440_2	atributo_2	194-201	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	en	en	SPS00	C1720294#C0332285	calificador#atributo	202-204	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	el	el	DA0MS0	-	-	205-207	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	momento	momento	NCMS000	C0040223#C0563597	calificador#fuerza_física	208-215	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	de	de	SPS00	C0332285	atributo	216-218	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	la	el	DA0FS0	-	-	219-221	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	evaluación	evaluación	NCFS000	C1261322	procedimiento	222-232	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	es	ser	VSIP3S0	-	-	233-235	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	bueno	bueno	AQ0MS0	C0205170	calificador	236-241	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	y	y	CC	C1706368	calificador	242-243	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
13	la	el	DA0FS0	-	-	244-246	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
14	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	247-258	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
15	física	físico	NCFS000	C0031809_2	procedimiento_2	259-265	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
16	es	ser	VSIP3S0	-	-	266-268	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
17	normal	normal	AQ0CS0	C0205307	calificador	269-275	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
18	.	.	Fp	-	-	275-276	749_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	277-279	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	los	el	DA0MP0	-	-	280-283	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	análisis	análisis	NCMN000	C0002778	calificador	284-292	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	destaca	destacar	VMIP3S0	-	-	293-300	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	leucocitosis	leucocitosis	NCFN000	C0023518#C0750426	trastorno#hallazgo	301-313	749_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
6	de	de	SPS00	C0332285	atributo	314-316	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	18.000/μl	18.000/μl		-	-	317-326	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	con	con	SPS00	C0332287	atributo	327-330	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	neutrofilia	neutrofilia	NCFS000	C3665444#C1282609#C0151683	trastorno#hallazgo	331-342	749_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-	-	-	-
10	del	del	SP+DA	-	-	343-346	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	92	92	Z	-	-	347-349	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
12	%	%	Ft	-	-	350-351	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
13	,	,	Fc	-	-	351-352	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
14	serie	serie	NCFS000	C0205549	calificador	353-358	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
15	roja	rojo	AQ0FS0	C1260956	calificador	359-363	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
16	y	y	CC	C1706368	calificador	364-365	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
17	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	366-375	749_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-	-	-	-
18	normales	normal	AQ0CP0	C0205307	calificador	376-384	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
19	;	;	Fx	-	-	384-385	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
20	creatinina	creatinina	NC00SC0	C0010294	sustancia	386-396	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
21	2,3	2.3	Z	-	-	397-400	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
22	mg	mg	NCMN000	-	-	401-403	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
23	/	/	Fh	-	-	403-404	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
24	dl	decilitro	NCMN000	C0439241	calificador	404-406	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
25	,	,	Fc	-	-	406-407	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
26	eFG	efg	NC00YL0	-	-	408-411	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
27	32	32	Z	-	-	412-414	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
28	ml	ml	NCMN000	C0439242	calificador	415-417	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
29	/	/	Fh	-	-	417-418	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
30	min	minuto	NCMN000	C0439232	calificador	418-421	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
31	y	y	CC	C1706368	calificador	422-423	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
32	PCR	pcr	NC00YL0	-	-	424-427	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
33	15	15	Z	-	-	428-430	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
34	mg	mg	NCMN000	-	-	431-433	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
35	/	/	Fh	-	-	433-434	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
36	L	l	NCFS000	-	-	434-435	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
37	(	(	Fpa	-	-	436-437	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
38	VN	valor_normal	NC00YL0	-	-	437-439	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
39	<	<	Fz	-	-	439-440	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
40	5	5		-	-	440-441	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
41	)	)	Fpt	-	-	441-442	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
42	.	.	Fp	-	-	442-443	749_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

1	La	el	DA0FS0	-	-	444-446	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
2	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	447-449	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
3	craneal	craneal	AQ0CS0	C0205096#C3163631	calificador	450-457	749_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-	-	-	-
4	no	no	RN	C1298908	calificador	458-460	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
5	muestra	mostrar	VMIP3S0	-	-	461-468	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
6	alteraciones	alteración	NCFP000	-	-	469-481	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-
7	.	.	Fp	-	-	481-482	749_QUEST_clinical_caseMIR	SENT4	-	-	-	-	-

1	El	el	DA0MS0	-	-	483-485	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
2	LCR	lcr	NC00SC0	C0007806	sustancia	486-489	749_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-	-	-	-
3	muestra	mostrar	VMIP3S0	-	-	490-497	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
4	un	un		C0205447_1	calificador_1	498-500	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
5	líquido	líquido	NCMS000	C0444611#C1304698#C1697794#C0302908#C1704353	calificador#hallazgo#sustancia	501-508	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
6	claro	claro	AQ0MS0	C2963144#C1306462#C0522503	calificador	509-514	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
7	con	con	SPS00	C0332287	atributo	515-518	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
8	200	200		-	-	519-522	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
9	leucocitos	leucocito	NCMP000	C0023516	célula	523-533	749_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-	-	-	-
10	/	/	Fh	-	-	533-534	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
11	μl	μl	AQ0CS00	-	-	534-536	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
12	(	(	Fpa	-	-	537-538	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
13	60	60	Z	-	-	538-540	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
14	%	%	Ft	-	-	541-542	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
15	linfocitos	linfocito	NCMP000	C0024264	célula	543-553	749_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-	-	-	-
16	)	)	Fpt	-	-	553-554	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
17	,	,	Fc	-	-	554-555	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
18	glucosa	glucosa	NCFS000	C0017725	sustancia#producto	556-563	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
19	80	80	Z	-	-	564-566	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
20	mg	mg	NCMN000	-	-	567-569	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
21	/	/	Fh	-	-	569-570	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
22	dl	decilitro	NCMN000	C0439241	calificador	570-572	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
23	,	,	Fc	-	-	572-573	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
24	proteínas	proteína	NCFP000	C0033684	sustancia	574-583	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
25	85	85	Z	-	-	584-586	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
26	mg	mg	NCMN000	-	-	587-589	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
27	/	/	Fh	-	-	589-590	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
28	dl	decilitro	NCMN000	C0439241	calificador	590-592	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
29	(	(	Fpa	-	-	593-594	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
30	VN	valor_normal	NC00YL0	-	-	594-596	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
31	<	<	Fz	-	-	596-597	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
32	50	50		-	-	597-599	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
33	)	)	Fpt	-	-	599-600	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
34	,	,	Fc	-	-	600-601	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
35	ADA	arteria_(coronaria)_descendente_anterior._adenosindesaminasa_(prueba_para_el_diagnóstico_de_tuberculosis)	NC00YL0	-	-	602-605	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
36	25	25		-	-	606-608	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
37	UI	ui	NC00SC0	C0439453	calificador	609-611	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
38	/	/	Fh	-	-	611-612	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
39	l	l	NCFS000	-	-	612-613	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
40	(	(	Fpa	-	-	614-615	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
41	VN	valor_normal	NC00YL0	-	-	615-617	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
42	<	<	Fz	-	-	617-618	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
43	15	15		-	-	618-620	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
44	)	)	Fpt	-	-	620-621	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
45	;	;	Fx	-	-	621-622	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
46	la	el	DA0FS0	-	-	623-625	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
47	tinción	tinción	NCFS000	C0061856#C0200966_1	sustancia#procedimiento_1	626-633	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
48	de	de	SPS00	C0061856#C0200966_2	sustancia#procedimiento_2	634-636	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
49	Gram	método_de_tinción_para_microorganismos_que_descubrió_el_médico_danés_de_igual_nombre	NC00YL0	C0061856#C0200966_3	sustancia#procedimiento_3	637-641	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
50	del	del	SP+DA	-	-	642-645	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
51	LCR	lcr	NC00SC0	C0007806	sustancia	646-649	749_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-	-	-	-
52	no	no	RN	C1298908	calificador	650-652	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
53	muestra	mostrar	VMIP3S0	-	-	653-660	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-
54	microorganismos	microorganismo	NCMP000	C0445623	organismo	661-676	749_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	Negacion	-	-	-
55	.	.	Fp	-	-	676-677	749_QUEST_clinical_caseMIR	SENT5	-	-	-	-	-

